Document Detail

Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction.
MedLine Citation:
PMID:  22883636     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The aim of this study was to evaluate the links between connexin43 (Cx43) expression, myocardial conduction velocity, and ventricular tachycardia in a model of healed myocardial infarction.
BACKGROUND: Post-infarction ventricular arrhythmias frequently cause sudden death. Impaired myocardial conduction has previously been linked to ventricular arrhythmias. Altered connexin expression is a potential source of conduction slowing identified in healed scar border tissues. The functional effect of increasing border-zone Cx43 has not been previously evaluated.
METHODS: Twenty-five Yorkshire pigs underwent anterior infarction by transient left anterior descending coronary artery occlusion, followed by weekly testing for arrhythmia inducibility. Twenty animals with reproducibly inducible sustained monomorphic ventricular tachycardia were randomized 2:1:1 to receive AdCx43, Adβgal, or no gene transfer. One week later, animals underwent follow-up electrophysiologic study and tissue assessment for several functional and molecular measures.
RESULTS: Animals receiving AdCx43 had less electrogram fractionation and faster conduction velocity in the anterior-septal border zone. Only 40% of AdCx43 animals remained inducible for ventricular tachycardia, while 100% of controls were inducible after gene transfer. AdCx43 animals had 2-fold higher Cx43 protein levels in the anterior-septal infarct border, with similar percents of phosphorylated and intercalated disk-localized Cx43 compared with controls.
CONCLUSIONS: These data mechanistically link Cx43 expression to slow conduction and arrhythmia susceptibility in the healed scar border zone. Targeted manipulation of Cx43 levels improved conduction velocity and reduced ventricular tachycardia susceptibility. Cx43 gene transfer represents a novel treatment strategy for post-infarction arrhythmias.
Ian D Greener; Tetsuo Sasano; Xiaoping Wan; Tomonori Igarashi; Maria Strom; David S Rosenbaum; J Kevin Donahue
Related Documents :
21643756 - Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with my...
21947626 - Percutaneous coronary intervention versus bypass surgery for left main coronary artery ...
22700956 - Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes.
2902496 - Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia.
12643426 - Use of intraaortic balloon pump in left ventricle rupture after mitral valve replacement.
15853176 - Stroke prevention in atrial fibrillation: current anticoagulation management and future...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-08-08
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  60     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-09-14     Completed Date:  2012-11-19     Revised Date:  2013-09-20    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1103-10     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio 44109, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Connexin 43 / administration & dosage,  genetics*
Disease Susceptibility / metabolism,  physiopathology,  therapy
Gene Transfer Techniques*
Genetic Therapy / methods
Heart Conduction System / metabolism,  physiopathology
Myocardial Infarction / complications,  genetics*,  therapy*
Random Allocation
Tachycardia, Ventricular / etiology,  genetics*,  therapy*
Grant Support
Reg. No./Substance:
0/Connexin 43
Comment In:
J Am Coll Cardiol. 2012 Sep 18;60(12):1111-3   [PMID:  22883635 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Longitudinal Left Ventricular Function for Prediction of Survival in Systemic Light-Chain Amyloidosi...
Next Document:  Toxicity assessment and analgesic activity investigation of aqueous acetone extracts of Sida acuta ...